NEUMORA THERAPEUTICS
14.57
08-10月-24 15:15:31
15 分の遅延
株式
+0.01
+0.07%
本日の幅
14.27 - 15.00
ISIN
N/A
ソース
NASDAQ
-
14 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
06 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
20 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
14 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
07 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics to Participate in Upcoming Conferences in May
06 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
15 4 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
13 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
07 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
22 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
12 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
27 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
01 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics to Participate in Upcoming Conferences in November
30 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
10 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Neumora Therapeutics Announces Pricing of Initial Public Offering
14 9 2023 20:49:04 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >